Ovoca Gold to relaunch as drug company

Ovoca Gold to relaunch as drug company

By Geoff Percival

Dublin-based mining firm, Ovoca Gold, is to reinvent itself as a biopharmaceutical business, via the $6.2m (€5.3m) reverse takeover of Russian drug development company, IVIX.

Ovoca will seek shareholder approval for the deal at an EGM in Dublin on July 27, which is unlikely to be anything more than a formality, as the news boosted Ovoca’s share price by 30%.

A successful outcome would also result in Ovoca Gold changing its name to Ovoca Bio.

IVIX is currently developing a proprietary drug, under the name Libicore, for the treatment of female sexual dysfunction, which affects 40% of women.

Ovoca, which has been focused on Russian gold-mining assets since 2004, has been reviewing its strategy for some time and was, last year, linked with diversification into the oil-and-gas exploration sector.

In its latest annual report, published in May, Ovoca said it closed 2017 with available financial assets of $19m and was continuing to seek ways to utilise its liquidity. 

Chief executive, Kirill Golovanov, said the company could shift direction and change its business focus.

“The enlarged group’s goal is to become a leader in the development and commercialisation of novel product candidates for the treatment of female sexual dysfunctions,” Ovoca said yesterday.

Ovoca has been locked in a legal battle, seeking money owed to it by bankrupt Russian oil-and-gas firm, Taymura, for some time, but recently admitted the chance of a successful conclusion to the matter “looks poor”.

More in this Section

Dublin Airport celebrates 80 years with reflection and expansionDublin Airport celebrates 80 years with reflection and expansion

Netflix chief confirms interest in deal with Harry and MeghanNetflix chief confirms interest in deal with Harry and Meghan

Sajid Javid issues post-Brexit warning to business leadersSajid Javid issues post-Brexit warning to business leaders

Markets jump despite fresh US-China concernsMarkets jump despite fresh US-China concerns


Frank Keogh did not want to get a hearing aid. He was afraid that it would make him look old. But now, just several weeks after having one fitted, he says that he can’t do without it.Hearing tests: A word in your ear

I see that a website describes the call of Canarian cory’s shearwaters as ‘waca waca’. It’s a mad, hysterical call, uttered when the parent birds arrive to feed their nestlings.Cory’s shearwaters show long-distance qualities

Is it too much to hope that an important public health matter, such as Lyme disease, will be an issue in the general election? There’s been a worrying reluctance by the authorities to face up to the extent of the disease here.Facing up to Lyme disease

A paper published in Current Biology examines the extinction of a colourful little bird which, until recently, thrived in the eastern US. With the appalling environmental catastrophe enveloping Australia, home to 56 of the world’s 370 parrot species, this account of the Carolina parakeet’s demise is timely.Trying to save the parrot is not all talk

More From The Irish Examiner